Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancerL Vahdat, G Raptis, D Fennelly, et al.Breast Cancer Research and Treatment|April 11, 2016
Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-upG Murtagh, T Lyons, E O'Connell, et al.Cancer Chemotherapy and Pharmacology|April 28, 2006
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancerR O'Connor, M O'Leary, J Ballot, et al.Seminars in Oncology|February 1, 1996
Sequential adjuvant therapy: the Memorial Sloan-Kettering Cancer Center experienceC Hudis, A Seidman, G Raptis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacyC Hudis, A Seidman, J Baselga, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancerG D'Andrea, D Fennelly, L Norton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancerC Aghajanian, D Fennelly, F Shapiro, et al.British Journal of Cancer|July 25, 2014
Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressiveA O'Toole, A J Michielsen, B Nolan, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 3, 2016
Microsatellite instability is associated with reduced disease specific survival in stage III colon cancerH M Mohan, E Ryan, I Balasubramanian, et al.BJS Open|December 5, 2018
Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair-deficient colorectal cancerÉ J Ryan, B Creavin, Y L Khaw, et al.Pageof 5